During the past decade, Clinical Research Center of Florida conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 17 clinical trials were completed, i.e. on average, 44.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 15 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Center of Florida" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Ferring Pharmaceuticals" with 3 trials sponsored, "GTx" with 3 trials sponsored, "Urovant Sciences GmbH" with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center of Florida" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator, "OSTAtistics" with 1 trials as a collaborator and "Ocular Therapeutix, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Center of Florida" are "Migraine" (4 trials), "Overactive Bladder" (3 trials), "Stress Urinary Incontinence" (3 trials), "Bladder Cancer" (2 trials) and "Irritable Bowel Syndrome" (2 trials). Many other conditions were trialed in "Clinical Research Center of Florida" in a lesser frequency.

Most popular intervention types in "Clinical Research Center of Florida" are "Drug" (33 trials), "Device" (4 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "GTx-024" (2 trials), "Galcanezumab" (2 trials), "Lasmiditan" (2 trials) and "Lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Center of Florida" are 28 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Center of Florida". undefined are not yet recruiting, 11 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Clinical Research Center of Florida, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Center of Florida, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".